FY2024 · ended Mar 31, 2024 · Revenue $0, -100.0% YoY · Filed Jun 26, 2025
Aethlon Medical, Inc. (AEMD) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. Free cash flow was -$7.0 million. As of Jun 30, 2026 it held $4.9 million in cash and investments and $255,052 in total debt.
Revenue
$0
-100.0% vs prior year
Net income
$-7.15M
+46.6% vs prior year
Operating cash flow (TTM)
$-7.18M
+5.7% vs year-ago TTM
Free cash flow
$-7.00M
+8.4% vs prior year
EPS
$-10.61
+87.6% vs prior year
Dividend per share
None
Shares outstanding
2.37M
-8.3% vs prior year
Net cash
$4.68M
as of Jun 30, 2026
Operating margin
-2072.0%
FY 2023
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- AEMD (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- NV
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 882291
- Former names
- BISHOP EQUITIES INC (until Mar 13, 2000)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Mar 31, 2026 |
FY 2025 Mar 31, 2025 |
FY 2024 Mar 31, 2024 |
FY 2023 Mar 31, 2023 |
FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| Revenue | — | — | $0 | $574,245 | $294,165 |
| Operating income | -$7.3M | -$9.3M | -$12.6M | -$11.9M | -$10.4M |
| Net income | -$7.2M | -$13.4M | -$12.2M | -$12.0M | -$10.4M |
| Diluted EPS | -$10.61 | -$85.77 | -$38.87 | -$5.86 | — |
| Operating cash flow | -$7.0M | -$7.6M | -$10.1M | -$10.5M | -$9.8M |
| Free cash flow | -$7.0M | -$7.6M | -$10.4M | -$11.4M | -$10.1M |
| Total assets | $6.3M | $7.4M | $8.2M | $17.5M | $19.4M |
| Total liabilities | $1.4M | $2.2M | $2.5M | $2.4M | $2.4M |
| Stockholders' equity | $4.9M | $5.1M | $5.8M | $15.1M | $17.0M |
| Cash and investments | $5.0M | $5.5M | $5.4M | $14.5M | — |
| Total debt | $336,718 | $649,751 | $940,316 | $1.2M | $729,410 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 9, 2026 | Oct 7, 2026 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Oct 5, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Oct 1, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Material agreement, Change in control, Regulation FD disclosure
|
Sep 17, 2026 | Sep 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 15, 2026 | Sep 11, 2026 |
| 8-K |
Current report
Other events
|
Aug 31, 2026 | Aug 28, 2026 |
All 1000 Aethlon Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.